End Cash: The amount of cash held by the company for the given period.
Utah Medical Products, Inc. (UTMD) had End Cash of $92.87M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$50.22M |
|
$16.64M |
|
$20.19M |
|
$30.04M |
|
$33.45M |
|
$16.78M |
|
$3.31M |
|
$20.09M |
|
$20.09M |
|
$16.64M |
|
$16.64M |
|
$16.64M |
|
$16.64M |
|
$16.78M |
|
$23.14M |
|
3.63M |
|
3.64M |
|
$4.58 |
|
$4.57 |
|
Balance Sheet Financials | |
$106.27M |
|
$10.55M |
|
$29.19M |
|
$135.46M |
|
$4.71M |
|
-- |
|
$2.44M |
|
$7.14M |
|
$128.31M |
|
$109.67M |
|
$128.31M |
|
3.63M |
|
Cash Flow Statement Financials | |
$22.28M |
|
$-0.64M |
|
$-4.17M |
|
$75.05M |
|
End Cash |
$92.87M |
$17.82M |
|
$0.23M |
|
$-4.28M |
|
-- |
|
Fundamental Metrics & Ratios | |
22.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
59.81% |
|
33.40% |
|
33.40% |
|
46.08% |
|
40.00% |
|
33.12% |
|
$21.64M |
|
-- |
|
-- |
|
-- |
|
0.37 |
|
2.11 |
|
14.81 |
|
24.64 |
|
12.96% |
|
15.17% |
|
12.28% |
|
12.96% |
|
$35.35 |
|
$5.95 |
|
$6.13 |